Portal de investigación
First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jabbour, Elias
- Kantarjian, Hagop
- Aldoss, Ibrahim
- Leonard, Jessica
- Gomez-Almaguer, David
- Baer, Maria
- Gambacorti-Passerini, Carlo
- McCloskey, James
- Minami, Yosuke
- Papayannidis, Cristina
- Rocha, Vanderson
- Rousselot, Philippe
- Vachhani, Pankit
- Wang, Eunice
- Hennessy, Meliessa
- Patel, Niti
- Vorog, Alexander
- Wang, Bingxia
- Yeh, Tammie
- Ribera, Jose-Maria
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Jabbour,E,Kantarjian,H,Aldoss,I,Montesinos,P,Leonard,J,Gomez,D,Baer,M et al. First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia. 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931:CIG MEDIA GROUP, LP. 2023 p.p. 245-245.